Literature DB >> 4429642

Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck.

J Lundy, H Wanebo, C Pinsky, E Strong, H Oettgen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4429642     DOI： 10.1016/0002-9610(74)90268-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN： 0002-9610            Impact factor:   2.565


× No keyword cloud information.
  7 in total

1.  Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma.

Authors:  Joseph A Califano; Zubair Khan; Kimberly A Noonan; Lakshmi Rudraraju; Zhe Zhang; Hao Wang; Steven Goodman; Christine G Gourin; Patrick K Ha; Carole Fakhry; John Saunders; Marshall Levine; Mei Tang; Geoffrey Neuner; Jeremy D Richmon; Ray Blanco; Nishant Agrawal; Wayne M Koch; Shanthi Marur; Donald T Weed; Paolo Serafini; Ivan Borrello
Journal:  Clin Cancer Res       Date:  2015-01-01       Impact factor: 12.531

2.  Immunobiology of operable breast cancer: an assessment of biologic risk by immunoparameters.

Authors:  H J Wanebo; P P Rosen; T Thaler; J A Urban; H F Oettgen
Journal:  Ann Surg       Date:  1976-09       Impact factor: 12.969

Review 3.  Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers.

Authors:  Ravindra Uppaluri; Gavin P Dunn; James S Lewis
Journal:  Cancer Immun       Date:  2008-12-04

4.  Histologic and immunohistochemical characterization of tumor and inflammatory infiltrates in oral squamous cell carcinomas treated with local multikine immunotherapy: the macrophage at the front line.

Authors:  Meora Feinmesser; Elimelech Okon; Ariel Schwartz; Ella Kaganovsky; Britta Hardy; Elena Aminov; Ben Nageris; Jaqueline Sulkes; Raphael Feinmesser
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-24       Impact factor: 2.503

5.  Observations on immunologic parameters in laryngeal cancer patients.

Authors:  K Makimoto; A Tamada; S Kishimoto; N Kanoh; T Hoshino
Journal:  Arch Otorhinolaryngol       Date:  1983

6.  Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically.

Authors:  G Cortesina; A De Stefani; E Galeazzi; G P Cavallo; F Badellino; G Margarino; C Jemma; G Forni
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

7.  Nutritional status and general immune competence in patients with head and neck cancer.

Authors:  G B Brookes; P Clifford
Journal:  J R Soc Med       Date:  1981-02       Impact factor: 18.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.